Fundraising FoxAngel Physicians Fund — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
MuRevamurevapt.comDec 2018
MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy.
Advanced ManufacturingHardwareHealthtechMedical DevicesBrecksville, US
Vedang Kothari(President)Sam Shelnutt(Vice-President of Engineering)inMichael Marotta(Vice President of Clinical Affairs)inPeter Broer(Director)Creighton Murch(Director)Austin Ruhle(Chief Financial Officer)
Co-investorsBand of AngelsJumpstart Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.